Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 99
of 5Next
1:
Related Articles, Links
Lakhan SE.
Free in PMC
From a Parkinson's disease expert: Rasagiline and the future of therapy.
Mol Neurodegener. 2007 Jul 6;2:13.
PMID: 17617893 [PubMed]
2:
Related Articles, Links
[No authors listed]
Abstract
Iometopane: (123)I beta-CIT, dopascan injection, GPI 200, RTI 55.
Drugs R D. 2003;4(5):320-2. Review.
PMID: 12952503 [PubMed - indexed for MEDLINE]
3:
Related Articles, Links
Tomioka H, Namba K.
Abstract
[Development of antituberculous drugs: current status and future prospects]
Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.
PMID: 17240921 [PubMed - indexed for MEDLINE]
4:
Related Articles, Links
Oldfield V, Keating GM, Perry CM.
Abstract
Rasagiline: a review of its use in the management of Parkinson's disease.
Drugs. 2007;67(12):1725-47. Review.
PMID: 17683172 [PubMed - indexed for MEDLINE]
5:
Related Articles, Links
Oldfield V, Keating GM, Perry CM.
Abstract
Spotlight on rasagiline in Parkinson's disease.
CNS Drugs. 2008;22(1):83-6.
PMID: 18072817 [PubMed]
6:
Related Articles, Links
Lin QS, Li BL.
Abstract
In Memory of Professor WANG Ying-Lai.
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2001;33(4):365-367.
PMID: 12040406 [PubMed - as supplied by publisher]
7:
Related Articles, Links
Chen JJ, Swope DM, Dashtipour K.
Abstract
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
Clin Ther. 2007 Sep;29(9):1825-49. Review.
PMID: 18035186 [PubMed - indexed for MEDLINE]
8:
Related Articles, Links
Rascol O, Brooks DJ, Melamed E, Oertel W, Poewe W, Stocchi F, Tolosa E; LARGO study group.
Abstract
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
Lancet. 2005 Mar 12-18;365(9463):947-54.
PMID: 15766996 [PubMed - indexed for MEDLINE]
9:
Related Articles, Links
Kaufman D.
Free Full Text
A Tribute to Bruce Chabner.
Oncologist. 1996;1(4):221-222.
PMID: 10387991 [PubMed - as supplied by publisher]
10:
Related Articles, Links
[No authors listed]
Abstract
Rasagiline. Parkinson's disease: a simple me-too.
Prescrire Int. 2006 Dec;15(86):220.
PMID: 17167927 [PubMed - indexed for MEDLINE]
11:
Related Articles, Links
[No authors listed]
Abstract
Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
BioDrugs. 2003;17(4):290-5.
PMID: 12899647 [PubMed - indexed for MEDLINE]
12:
Related Articles, Links
Mandel S, Weinreb O, Amit T, Youdim MB.
Abstract
Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives.
Brain Res Brain Res Rev. 2005 Apr;48(2):379-87. Review.
PMID: 15850677 [PubMed - indexed for MEDLINE]
13:
Related Articles, Links
Siddiqui MA, Plosker GL.
Abstract
Rasagiline.
Drugs Aging. 2005;22(1):83-91; discussion 93-4. Review.
PMID: 15663351 [PubMed - indexed for MEDLINE]
14:
Related Articles, Links
Parkinson Study Group.
Free Full Text
A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.
Arch Neurol. 2004 Apr;61(4):561-6.
PMID: 15096406 [PubMed - indexed for MEDLINE]
15:
Related Articles, Links
Rabey JM, Sagi I, Huberman M, Melamed E, Korczyn A, Giladi N, Inzelberg R, Djaldetti R, Klein C, Berecz G; Rasagiline Study Group.
Abstract
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa.
Clin Neuropharmacol. 2000 Nov-Dec;23(6):324-30.
PMID: 11575866 [PubMed - indexed for MEDLINE]
16:
Related Articles, Links
Parkinson Study Group.
Free Full Text
A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
Arch Neurol. 2005 Feb;62(2):241-8.
PMID: 15710852 [PubMed - indexed for MEDLINE]
17:
Related Articles, Links
Guay DR.
Abstract
Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
Am J Geriatr Pharmacother. 2006 Dec;4(4):330-46. Review.
PMID: 17296539 [PubMed - indexed for MEDLINE]
18:
Related Articles, Links
Youdim MB, Amit T, Falach-Yogev M, Bar Am O, Maruyama W, Naoi M.
Abstract
The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline.
Biochem Pharmacol. 2003 Oct 15;66(8):1635-41. Review.
PMID: 14555244 [PubMed - indexed for MEDLINE]
19:
Related Articles, Links
Stocchi F.
Abstract
Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease.
Int J Clin Pract. 2006 Feb;60(2):215-21. Review.
PMID: 16451296 [PubMed - indexed for MEDLINE]
20:
Related Articles, Links
[No authors listed]
Abstract
Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D. 2005;6(2):120-7. Review.
PMID: 15777106 [PubMed - indexed for MEDLINE]
Items 1 - 20 of 99
of 5Next